Perioperative and periprocedural bridging and bleeding management;Blutungsmanagement, perioperatives und periprozedurales Bridging - Vorschlag praktischer Strategien für die neuen oralen Antikoagulantien

Klinikarzt

Volumn 41, Issue SUPPL. 1, 2012, Pages 26-32

  Sauer, Hartmut ^a   Wankmüller, Herwig ^a   Leschke, Matthias ^a  

^a KLINIKUM ESSLINGEN   (Germany)

Author keywords

Anticoagulation; bleeding; Dabigatran; perioperative bridging; Rivaroxaban; trauma

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; DABIGATRAN; RIVAROXABAN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL PRACTICE; DRUG INDICATION; DRUG SAFETY; EMERGENCY CARE; HUMAN; OFF LABEL DRUG USE; SURGICAL PATIENT;

EID: 84859799298     PISSN: 03412350     EISSN: 14393859     Source Type: Journal    
DOI: 10.1055/s-0032-1312459     Document Type: Article

References (11)

1. Harper P, Young L, Merriman E. Bleeding Risk with Dabigatran in the Frail Elderly. N Engl J Med: 2012; 366 864 866
2. Schepke M, Pötzsch B. Leitlinien der DGVS. Endoskopie bei Patienten mit erhöhtem Blutungsrisiko. http://www.DGVS.de/Leitlinien/1.3. Blutungsrisiko.pdf
3. Leitlinien der DGAI Rückenmarknahe Regionalanästhesien und Thromboembolieprophylaxe/Antithrombotische Medikation. Anästh Intensivmed: 2007; 48 109 124
4. Eerenberg ES. Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate. Circulation: 2011; 124 1573 1579
5. Huisman MV, Lip GYH, Diener HC et al. Dabigatran etexilate for stroke prevention in Patients with atrial fibrillation: Resolving uncertainties in routine practice. Thromb haemost prepublished online February: 2012; 107
6. Mega JL., Braunwald E, Wiviott SD et al. ATLAS ACS 2-TIMI 51 Investigators Rivaroxaban in Patients with a Recent Acute Coronary Syndrome. N Engl JMed: 2012; 366 9 19
7. Mega JL, Braunwald E, Mohanavelu S et al. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet: 2009; 374 29 29
8. Van Ryn J, Stangier J, Haertter S et al. Dabigatranetexilate - a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost: 2010; 103 1116 1127
9. Cotton BA, McCarthy JJ, Holcomb JB. Acutely injured patients on dabigatran. N Eng J Med: 2011; 365 2038 2040
10. Eikelbohm JW, Cotton BA. More on Acutely Injured Patients on Dabigatran. N Eng J Med: 2012; 366 863 864
11. Camm AJ et al. Guidelines for the management of atrial fibrillation. Europ Heart J: 2010